Search clinical trials for: quetiapine (Seroquel XR)

Total 880 results

Jiangsu HengRui Medicine Co., Ltd.

Unknown

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy

Diabetes Mellitus, Type II
Aarhus University Hospital

Completed

Effects of Metformin Treatment on Myocardial Efficiency in Patients With Heart Failure (METRONOME)

Heart Failure, Systolic

Denmark
Shandong Suncadia Medicine Co., Ltd.

Not yet recruiting

A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese Subjects

Type II Diabetes
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder

Panic Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients

Bipolar Disorder
Shanghai Jiao Tong University School of Medicine

Unknown

To Evaluate the Efficiency and Safety of Quetiapine Fumarate in the Treatment of Acute Manic Patients With Bipolar Disorder.

Bipolar Disorder

China
University of South Florida
AstraZeneca

Completed

Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD

Generalized Anxiety Disorder | Bipolar Disorder | Panic Disorder

United States
Medical University of Vienna

Completed

Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions

Ocular Physiology | Regional Blood Flow

Austria
Creighton University
AstraZeneca

Completed

Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia

Schizophrenia | Schizoaffective Disorder | Substance Abuse | Substance Dependence

United States
Abbott Medical Devices

Active, not recruiting

Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT)

Neuropathic Pain | Refractory Pain | Chronic Low-Back Pain

United States
GlaxoSmithKline

Completed

The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis

Arthritis, Rheumatoid

Lithuania, United Kingdom
Mayo Clinic
Abbott Medical Devices

Completed

Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)

Polycystic Ovary Syndrome

United States
Janssen Research & Development, LLC

Completed

A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants

Healthy

United States
Sanofi

Completed

TREAD-20 Extension - Treatment of Knee Pain Due to Osteoarthritis

Osteoarthritis

United States
Rhodes Pharmaceuticals, L.P.

Completed

Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD (PK003)

Attention-Deficit/Hyperactivity Disorder

United States
University of Washington
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Alkermes, Inc.

Completed

Harm Reduction With Pharmacotherapy (HaRP) (HaRP)

Alcohol Use Disorder

United States
AstraZeneca

Completed

Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder

Alcohol Dependence | Bipolar I Disorder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder

Panic Disorder

United States
Beth Israel Deaconess Medical Center
Veloxis Pharmaceuticals

Not yet recruiting

Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes

Medication Adherence | Renal Transplant
Friends Research Institute, Inc.

Recruiting

Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail

Opioid-use Disorder

United States
Supernus Pharmaceuticals, Inc.

Completed

Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients

Epilepsies, Partial

United States
VA Office of Research and Development

Recruiting

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis (C-SAPP)

Parkinson's Disease Psychosis

United States
ACADIA Pharmaceuticals Inc.

Terminated

Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine

Parkinson's Disease

United States
Jin Yuan

Unknown

Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry Eye

Dry Eye | Tear Film Insufficiency

China
Michele Staton
National Institute on Drug Abuse (NIDA)

Completed

Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder

Opioid Dependence

United States
University of Minnesota

Withdrawn

Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study

Obesity | Insulin Resistance
University of California, Los Angeles
Alkermes, Inc.

Completed

Injectable Pharmacotherapy for Opioid Use Disorders (IPOD) (IPOD)

Opioid Use Disorders

United States
GlaxoSmithKline

Terminated

Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease

Alzheimer's Disease

United Kingdom
Mahidol University

Unknown

Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma

Glaucoma | Ocular Surface Disease

Thailand
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder

Major Depressive Disorder
University of Campinas, Brazil

Unknown

Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma (METDEXA-MM)

Multiple Myeloma

Brazil
Janssen Research & Development, LLC

Completed

A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin Extended Release Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants

Healthy

United States
AstraZeneca

Completed

Quetiapine Augmentation in Severe Obsessive Compulsive Disorder

Obsessive Compulsive Disorder

Germany
Brigham and Women's Hospital
Arthritis Foundation

Recruiting

Preventing Injured Knees From osteoArthritis: Severity Outcomes (PIKASO)

Osteoarthritis, Knee | Post-traumatic Osteoarthritis | ACL Tear

United States
AHS Cancer Control Alberta

Terminated

Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate (PREMIUM)

Prostatic Neoplasm

Canada
Dong-A ST Co., Ltd.

Unknown

Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.

Diabetes Mellitus, Type 2

Korea, Republic of
Philip Kern
University of Alabama at Birmingham

Completed

Metformin to Augment Strength Training Effective Response in Seniors (MASTERS)

Aging

United States
University of Washington
University of Miami; University of Alabama at Birmingham; New York University; University... and other collaborators

Completed

Project to Improve Symptoms and Mood in People With Spinal Cord Injury (PRISMS)

Major Depressive Disorder | Spinal Cord Injuries | Dysthymia

United States
Novartis Pharmaceuticals

Completed

A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
Indiana Hemophilia &Thrombosis Center, Inc.

Active, not recruiting

Metformin Use in Cardiac Fibrosis in PAI-1 Deficiency

Plasminogen Activator Inhibitor-1 Deficiency | Cardiac Fibrosis

United States
Handok Inc.

Completed

A Study to Evaluate the Effect of Food on Fixed-Dose Combination of MP-513 10 mg and Metformin XR 750 mg

Healthy Volunteers

Korea, Republic of
Ferring Pharmaceuticals

Completed

Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMC

Osteoarthritis

United States
University of Utah
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Recruiting

Metformin for Fibromyalgia Symptoms (INFORM Trial)

Fibromyalgia Syndrome

United States
Gwendolyn Sowa

Completed

Effects of Metformin on Low Back Pain

Low Back Pain

United States
CVRx, Inc.

Unknown

BAROSTIM NEO System in the Treatment of Heart Failure

Heart Failure

Canada, Germany, France, Italy
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)

Type 2 Diabetes Mellitus
Janssen Research & Development, LLC

Completed

A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants

Healthy

United States
AstraZeneca

Completed

Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR

Diabetes Mellitus

United States
Allergan

Completed

Trospium Chloride XR in Obese Female Patients With Overactive Bladder

Obesity | Overactive Bladder | Incontinence

United States
AstraZeneca

Completed

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder (AMBER)

Major Depressive Disorder

Korea, Republic of, Mexico, South Africa, China, Finland, Canada, Spain, Philippines, Malaysia

3

Subscribe